Viewing Study NCT06283550


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2025-12-28 @ 12:04 PM
Study NCT ID: NCT06283550
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-17
First Post: 2024-02-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy
Sponsor: Innovaderm Research Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module